Categories 2010-2016 (n=136) 2017-2020 (n=160)
Age at diagnosis (years) Mean (SD) 7.9(4) 6.9 (4.2)
Median (IQR) 7.8(4.5-11.2) 6 (3, 10)
Sex Male 73(54%) 91 (57%)
Female 63(46%) 69 (43%)
Distance to MTRH (n=136) (n=157)
<100 Km 54(40%) 32 (20%)
>100 Km 82(60%) 125 (80%)
Duration of symptoms before admission at MTRH (N=132) (N=156)
<1 month 31(23%) 57 (36%)
1-3 months 68(52%) 72 (45%)
> 3months 33(25%) 27 (17%)
Health insurance (NHIF) status (n=136) (n=123)
NHIF at the start of treatment 71(52%) 80 (65%)
NHIF during treatment 43(32% 40 (33%)
No NHIF 22(16%) 3 (2%)
WBC count at diagnosis (x109 /L) (n=123) <50 81 (66%)
≥50 42 (34%)
ALL immunophenotypes (n=123) B-cell precursor 33 (27%)
T-cell 8 (6%)
Not determined 82 (67%)
CNS status (n=123) Negative 94 (76%)
Positive 24 (20%)
Not determined 5 (4%)